Gilead Sciences Inc.

NASDAQ: GILD
Share price (3/25/25): $107.89
Market cap (3/25/25): $134 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Third party tender offer – amended

Third party tender offer – amended

Ownership Filter

Wilfong Diane E.

Kalaris Therapeutics Inc.

Dickinson Andrew D

Dickinson Andrew D

Mercier Johanna

News Filter

Change in Directors, Officers or Compensation

Announces Fourth Quarter and Full Year 2024 Financial Results

Appoints Dietmar Berger, MD, Phd, as Chief Medical Officer

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Other Events, Financial Statements or Exhibits

Announces Third Quarter 2024 Financial Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Letter to shareholders

Other Filter

Scanned paper annual report submission

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC